Type 2 diabetes. Type 2 diabetes mellitus with hyperosmolarity
Conditions
Interventions
Intervention 1: Intervention group: The first group received 100 mg of sitagliptin daily for 3 months. Intervention 2: Intervention group: The second group received 30 mg of glutathione daily for 3 mo
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 55 Years
Inclusion criteria
Inclusion criteria: Age 45-55 years HbA1C is more than 7 in less than 8. BMI is greater than 25 and less than 30.
Exclusion criteria
Exclusion criteria: Having any cardiovascular, inflammatory, autoimmune disease Taking warfarin Presence of infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High-Sensitivity C-Reactive Protein. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test.;HDL Cholesterol. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test.;Fibrogen. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fast blood sugar. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test.;Cholestrol. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test.;Triglyceride. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Blood Test.;Body Mass Index. Timepoint: Baseline and 3 months after the treatment. Method of measurement: Weigh. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farzad Najafipour
Tabriz University of Medical Sciences
Outcome results
None listed